FDA Clears Box DICOM Viewer as Class II Medical Device

Article

The FDA has cleared Box DICOM Viewer, part of the Box for Healthcare solution.

Box has received FDA clearance for its DICOM Viewer, the company announced at HIMSS 2016.

Box, an enterprise content management platform, developed a solution tailored for hospitals that streamlines referral management, enables medical professionals to share and view DICOM files, and provides access to critical data that is often “trapped in proprietary hospital-based enterprise systems,” a release said.

The Box DICOM viewer is part of the Box for Healthcare solution, which includes a content management platform that allows hospitals to securely share and manage content in the cloud from any device in real time; Box Governance, which enables customers to comply with regulatory policies, satisfy e-discovery requests, and manage sensitive information; Box Consulting Services, which provides expertise to help customers transform their clinical workflows with custom integration; and Partner Integration Capabilities, which supports HIPAA-compliant faxing services and communication with hospital based record systems, the company said.

The Box DICOM Viewer is now generally available and has been FDA cleared as a Class II Medical Device, and can therefore be used for diagnostic purposes.[[{"type":"media","view_mode":"media_crop","fid":"46782","attributes":{"alt":"Box DICOM Viewer","class":"media-image","id":"media_crop_3507474655434","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5454","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"Image courtesy of Box.","typeof":"foaf:Image"}}]]

Recent Videos
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.